Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(233)
•••
itntdf
X
View Profile
View Bullboard History
Comment by
itntdf
on Nov 25, 2024 10:15pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
and, if pela tracks the averages, it will take approximately 11 months for the surrogate enpoint to be measured such that aa can be granted. now the question seems to be will some big pharma jump on
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 6:56pm
RE:RE:RE:Pancreatic surgeon Dr. Marty Makary appointed head of FDA
... neither Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research (CBER), nor [ Jefferies] analysts anticipate major changes to the FDA’s oversight of therapeutics.
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Post by
Noteable
on Nov 25, 2024 6:45pm
OT: Asthma drug "Singular" linked to mental health problems
Launched in 1998, the risk of “serious neuropsychiatric events” including agitation, hostility, depression, anxiousness, insomnia and obsessive-compulsive symptoms in patients who were taking the
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 3:55pm
RE:What YouTube CEO shared before she died of lung cancer
In the message, Susan Wojcicki said that she and her husband, Dennis Troper, had actively supported cancer research before her diagnosis. Afterwards, the couple donated millions of dollars for “early
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Post by
Noteable
on Nov 25, 2024 3:53pm
What YouTube CEO shared before she died of lung cancer
“At the end of 2022, I was diagnosed with lung cancer,” Wojcicki’s message began. “I had almost no symptoms and was running a few miles a day at the time. I had never smoked so I was totally shocked
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 2:59pm
RE:RE:RE:RE:Biotech industry readies for " Pharma M&A Spree"
November 25, 2024 - Pfizer’s sales surge in Q3. In the third quarter, part of Pfizer’s revenue increase (PDF) from $13.2 billion to $17.7 billion could be attributed to its acquisition
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 2:36pm
RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
With Replimmune leading the way on Accelerated Approval (AA) and the FDA granting Replimmune's intratumorally (IT) delivered OV therapy Breakthrough Therapy Designation (BTD), ONCY's
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 2:33pm
RE:CD8+ TiLs and T-cell exhaustion
CD8+ TiL cells are critical mediators of cytotoxic effector function in cancer, however, in cancer, CD8+ TiL cells undergo a progressive loss of cytokine production and cytotoxicity, a state
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 2:23pm
RE:RE:RE:Biotech industry readies for " Pharma M&A Spree"
With the appointment of John Hopkins pancreatic surgeon Dr. Marty Makary to the position of FDA Commissioner-elect , a Republican administration may be friendlier to large deals particularly
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 2:14pm
RE:RE:Pancreatic surgeon Dr. Marty Makary appointed head of FDA
In May 2024 COSM recognized that " Durable Antitumor Immunity After Successful Primary Tumor Responses to IO Therapy is Conferred by CD8 Tex-stem Cells Residing Within Regional Lymphatics
...more
(209)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 25, 2024 1:43pm
RE:RE:RE:RE:Hey Shorty…too bad you didn’t cover….
Like I thought... the only news is more worthless posts from ole unnoteable.
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 1:40pm
RE:RE:Pancreatic surgeon Dr. Marty Makary appointed head of FDA
May 2024 - Advance Program for the American Head & Neck Society (AHNS) 2024 Meeting at COSM Catalyzing Practice Change Through Translational Clinical Research John Conley Lecture Blind Spots
...more
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 25, 2024 1:23pm
RE:Pancreatic surgeon Dr. Marty Makary appointed head of FDA
Further to ONCY's clinical development program, FDA Commissioner- elect Dr. Marty Makary was a collaborating author on a 2021 John Hopkins study that showed that a higher density of TLAs (TiLs
...more
(209)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 25, 2024 1:07pm
RE:RE:RE:Hey Shorty…too bad you didn’t cover….
So what's the "big" news you pumpers are touting this week... have you been eavesdropping in the boardroom again...
(5356)
•••
Noteable
X
View Profile
View Bullboard History
Post by
Noteable
on Nov 25, 2024 1:00pm
Pancreatic surgeon Dr. Marty Makary appointed head of FDA
https://www.texasstandard.org/stories/blind-spots-book-makary-modern-medicine-misconceptions-mistakes-health-care/
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income